Wireless Computing in Medicine

Name: Wireless Computing in Medicine | From Nano to Cloud with Ethical and Legal Implications
Brand: Wiley
Price: 132.99 EUR
Availability: OnlineOnly

From Nano to Cloud with Ethical and Legal Implications

Mary Eshaghian-Wilner(Herausgeber*in)

Wiley (Verlag)

Erschienen am 10. Juni 2016

664 Seiten

E-Book

PDF mit Adobe-DRM

Systemvoraussetzungen

978-1-118-99360-6 (ISBN)

132,99 €inkl. 7% MwSt.

Systemvoraussetzungen

für PDF mit Adobe-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Provides a comprehensive overview of wireless computing in medicine, with technological, medical, and legal advances
This book brings together the latest work of leading scientists in the disciplines of Computing, Medicine, and Law, in the field of Wireless Health. The book is organized into three main sections. The first section discusses the use of distributed computing in medicine. It concentrates on methods for treating chronic diseases and cognitive disabilities like Alzheimer's, Autism, etc. It also discusses how to improve portability and accuracy of monitoring instruments and reduce the redundancy of data. It emphasizes the privacy and security of using such devices. The role of mobile sensing, wireless power and Markov decision process in distributed computing is also examined. The second section covers nanomedicine and discusses how the drug delivery strategies for chronic diseases can be efficiently improved by Nanotechnology enabled materials and devices such as MENs and Nanorobots. The authors will also explain how to use DNA computation in medicine, model brain disorders and detect bio-markers using nanotechnology. The third section will focus on the legal and privacy issues, and how to implement these technologies in a way that is a safe and ethical.
* Defines the technologies of distributed wireless health, from software that runs cloud computing data centers, to the technologies that allow new sensors to work
* Explains the applications of nanotechnologies to prevent, diagnose and cure disease
* Includes case studies on how the technologies covered in the book are being implemented in the medical field, through both the creation of new medical applications and their integration into current systems
* Discusses pervasive computing's organizational benefits to hospitals and health care organizations, and their ethical and legal challenges
Wireless Computing in Medicine: From Nano to Cloud with Its Ethical and Legal Implications is written as a reference for computer engineers working in wireless computing, as well as medical and legal professionals. The book will also serve students in the fields of advanced computing, nanomedicine, health informatics, and technology law.

Weitere Details

Weitere Ausgaben

Person

Inhalt

1 - Title Page [Seite 5]
2 - Copyright Page [Seite 6]
3 - Contents [Seite 7]
4 - Contributors [Seite 15]
5 - Foreword [Seite 19]
6 - Preface [Seite 21]
7 - Part I Introduction [Seite 25]
7.1 - CHAPTER 1 INTRODUCTION TO WIRELESS COMPUTING IN MEDICINE [Seite 27]
7.1.1 - 1.1 INTRODUCTION [Seite 27]
7.1.2 - 1.2 DEFINITION OF TERMS [Seite 29]
7.1.3 - 1.3 BRIEF HISTORY OF WIRELESS HEALTHCARE [Seite 29]
7.1.4 - 1.4 WHAT IS WIRELESS COMPUTING? [Seite 30]
7.1.5 - 1.5 DISTRIBUTED COMPUTING [Seite 31]
7.1.6 - 1.6 NANOTECHNOLOGY IN MEDICINE [Seite 34]
7.1.7 - 1.7 ETHICS OF MEDICAL WIRELESS COMPUTING [Seite 36]
7.1.8 - 1.8 PRIVACY IN WIRELESS COMPUTING [Seite 37]
7.1.9 - 1.9 CONCLUSION [Seite 38]
7.1.10 - REFERENCES [Seite 38]
7.2 - CHAPTER 2 NANOCOMPUTING AND CLOUD COMPUTING [Seite 41]
7.2.1 - 2.1 INTRODUCTION [Seite 41]
7.2.2 - 2.2 NANOCOMPUTING [Seite 42]
7.2.3 - 2.3 CLOUD COMPUTING [Seite 54]
7.2.4 - 2.4 CONCLUSION [Seite 61]
7.2.5 - ACKNOWLEDGMENT [Seite 61]
7.2.6 - REFERENCES [Seite 61]
8 - Part II Pervasive Wireless Computing in Medicine [Seite 65]
8.1 - CHAPTER 3 PERVASIVE COMPUTING IN HOSPITALS [Seite 67]
8.1.1 - 3.1 INTRODUCTION [Seite 67]
8.1.2 - 3.2 ARCHITECTURE OF PERVASIVE COMPUTING IN HOSPITALS [Seite 69]
8.1.3 - 3.3 SENSORS, DEVICES, INSTRUMENTS, AND EMBEDDED SYSTEMS [Seite 73]
8.1.4 - 3.4 DATA ACQUISITION IN PERVASIVE COMPUTING [Seite 83]
8.1.5 - 3.5 SOFTWARE SUPPORT FOR CONTEXT?AWARE AND ACTIVITY SHARING SERVICES [Seite 87]
8.1.6 - 3.6 DATA AND INFORMATION SECURITY [Seite 90]
8.1.7 - 3.7 CONCLUSION [Seite 95]
8.1.8 - ACKNOWLEDGMENT [Seite 95]
8.1.9 - REFERENCES [Seite 96]
8.2 - CHAPTER 4 DIAGNOSTIC IMPROVEMENTS: TREATMENT AND CARE [Seite 103]
8.2.1 - 4.1 INTRODUCTION [Seite 103]
8.2.2 - 4.2 SYSTEM DESIGN [Seite 105]
8.2.3 - 4.3 BODY SENSOR NETWORK [Seite 106]
8.2.4 - 4.4 PORTABLE SENSORS [Seite 108]
8.2.5 - 4.5 WEARABLE SENSORS [Seite 112]
8.2.6 - 4.6 IMPLANTABLE SENSORS [Seite 118]
8.2.7 - 4.7 WIRELESS COMMUNICATION [Seite 119]
8.2.8 - 4.8 MOBILE BASE UNIT [Seite 121]
8.2.9 - 4.9 CONCLUSION AND CHALLENGES [Seite 122]
8.2.10 - ACKNOWLEDGMENT [Seite 123]
8.2.11 - REFERENCES [Seite 123]
8.3 - CHAPTER 5 COLLABORATIVE OPPORTUNISTIC SENSING OF HUMAN BEHAVIOR WITH MOBILE PHONES [Seite 131]
8.3.1 - 5.1 HEALTH AND MOBILE SENSING [Seite 131]
8.3.2 - 5.2 THE InCense SENSING TOOLKIT [Seite 134]
8.3.3 - 5.3 SENSING CAMPAIGN 1:?DETECTING BEHAVIORS ASSOCIATED WITH THE FRAILTY SYNDROME AMONG OLDER ADULTS [Seite 143]
8.3.4 - 5.4 SENSING CAMPAIGN 2:?DETECTING PROBLEMATIC BEHAVIORS AMONG ELDERS WITH DEMENTIA [Seite 147]
8.3.5 - 5.5 DISCUSSION [Seite 155]
8.3.6 - 5.6 CONCLUSIONS AND FUTURE WORK [Seite 156]
8.3.7 - REFERENCES [Seite 157]
8.4 - CHAPTER 6 PERVASIVE COMPUTING TO SUPPORT INDIVIDUALS WITH COGNITIVE DISABILITIES [Seite 161]
8.4.1 - 6.1 INTRODUCTION [Seite 161]
8.4.2 - 6.2 WEARABLE AND MOBILE SENSING PLATFORMS TO EASE THE RECORDING?OF DATA RELEVANT TO CLINICAL CASE ASSESSMENT [Seite 168]
8.4.3 - 6.3 AUGMENTED REALITY AND MOBILE?AND TANGIBLE COMPUTING TO SUPPORT COGNITION [Seite 175]
8.4.4 - 6.4 SERIOUS GAMES AND EXERGAMES TO SUPPORT MOTOR IMPAIRMENTS [Seite 182]
8.4.5 - 6.5 CONCLUSIONS [Seite 192]
8.4.6 - ACKNOWLEDGMENTS [Seite 196]
8.4.7 - REFERENCES [Seite 196]
8.5 - CHAPTER 7 WIRELESS POWER FOR IMPLANTABLE DEVICES: A TECHNICAL REVIEW [Seite 211]
8.5.1 - 7.1 INTRODUCTION [Seite 211]
8.5.2 - 7.2 HISTORY OF WIRELESS POWER [Seite 213]
8.5.3 - 7.3 APPROACH OF WIRELESS POWER TRANSMISSION [Seite 215]
8.5.4 - 7.4 A DETAILED EXAMPLE OF MAGNETIC COUPLING RESONANCE [Seite 218]
8.5.5 - 7.5 POPULAR STANDARDS [Seite 223]
8.5.6 - 7.6 WIRELESS POWER TRANSMISSION IN MEDICAL USE [Seite 225]
8.5.7 - 7.7 CONCLUSION [Seite 228]
8.5.8 - ACKNOWLEDGMENTS [Seite 229]
8.5.9 - REFERENCES [Seite 229]
8.6 - CHAPTER 8 ENERGY-EFFICIENT PHYSICAL ACTIVITY DETECTION IN WIRELESS BODY AREA NETWORKS [Seite 235]
8.6.1 - 8.1 INTRODUCTION [Seite 235]
8.6.2 - 8.2 KNOWME PLATFORM [Seite 239]
8.6.3 - 8.3 ENERGY IMPACT OF DESIGN CHOICES [Seite 241]
8.6.4 - 8.4 PROBLEM FORMULATION [Seite 252]
8.6.5 - 8.5 SENSOR SELECTION STRATEGIES [Seite 256]
8.6.6 - 8.6 ALTERNATIVE PROBLEM FORMULATION [Seite 261]
8.6.7 - 8.7 SENSOR SELECTION STRATEGIES FOR THE ALTERNATIVE FORMULATION [Seite 265]
8.6.8 - 8.8 EXPERIMENTS [Seite 268]
8.6.9 - 8.9 RELATED WORK [Seite 278]
8.6.10 - 8.10 CONCLUSION [Seite 280]
8.6.11 - ACKNOWLEDGMENTS [Seite 281]
8.6.12 - REFERENCES [Seite 281]
8.7 - CHAPTER 9 MARKOV DECISION PROCESS FOR ADAPTIVE CONTROL OF DISTRIBUTED BODY SENSOR NETWORKS [Seite 287]
8.7.1 - 9.1 INTRODUCTION [Seite 287]
8.7.2 - 9.2 RATIONALE FOR MDP FORMULATION [Seite 289]
8.7.3 - 9.3 RELATED WORK [Seite 292]
8.7.4 - 9.4 PROBLEM STATEMENT, ASSUMPTIONS, AND APPROACH [Seite 293]
8.7.5 - 9.5 MDP MODEL FOR MULTIPLE SENSOR NODES [Seite 296]
8.7.6 - 9.6 COMMUNICATION [Seite 298]
8.7.7 - 9.7 SIMULATION RESULTS [Seite 300]
8.7.8 - 9.8 CONCLUSIONS [Seite 316]
8.7.9 - ACKNOWLEDGMENT [Seite 318]
8.7.10 - REFERENCES [Seite 318]
9 - Part III Nanoscale Wireless Computing in Medicine [Seite 321]
9.1 - CHAPTER 10 AN INTRODUCTION TO NANOMEDICINE [Seite 323]
9.1.1 - 10.1 INTRODUCTION [Seite 323]
9.1.2 - 10.2 NANOMEDICAL TECHNOLOGY [Seite 325]
9.1.3 - 10.3 DETECTION [Seite 327]
9.1.4 - 10.4 TREATMENT [Seite 329]
9.1.5 - 10.5 BIOCOMPATIBILITY [Seite 333]
9.1.6 - 10.6 POWER [Seite 335]
9.1.7 - 10.7 COMPUTER MODELING [Seite 337]
9.1.8 - 10.8 RESEARCH INSTITUTIONS [Seite 339]
9.1.9 - 10.9 CONCLUSION [Seite 341]
9.1.10 - ACKNOWLEDGMENTS [Seite 341]
9.1.11 - REFERENCES [Seite 341]
9.2 - CHAPTER 11 NANOMEDICINE USING MAGNETO-ELECTRIC NANOPARTICLES [Seite 347]
9.2.1 - 11.1 INTRODUCTION [Seite 347]
9.2.2 - 11.2 OVERVIEW OF MENs [Seite 348]
9.2.3 - 11.3 EXPERIMENT 1: EXTERNALLY CONTROLLED ON-DEMAND RELEASE OF ANTI-HIV DRUG AZTTP USING MENS AS CARRIERS [Seite 349]
9.2.4 - 11.4 EXPERIMENT 2: MENS TO ENABLE FIELD?CONTROLLED HIGH?SPECIFICITY DRUG DELIVERY TO ERADICATE OVARIAN CANCER CELLS [Seite 355]
9.2.5 - 11.5 EXPERIMENT 3: MAGNETOELECTRIC "SPIN" ON STIMULATING THE BRAIN [Seite 363]
9.2.6 - 11.6 BIOCERAMICS: BONE REGENERATION AND MNS [Seite 372]
9.2.7 - 11.7 CONCLUSION [Seite 375]
9.2.8 - REFERENCES [Seite 377]
9.3 - CHAPTER 12 DNA COMPUTATION IN MEDICINE [Seite 383]
9.3.1 - 12.1 BACKGROUND FOR THE NON?BIOLOGIST [Seite 383]
9.3.2 - 12.2 INTRODUCTION [Seite 386]
9.3.3 - 12.3 IN VITRO COMPUTING [Seite 388]
9.3.4 - 12.4 COMPUTATION IN VIVO [Seite 394]
9.3.5 - 12.5 CHALLENGES [Seite 397]
9.3.6 - 12.6 GLIMPSE INTO THE FUTURE [Seite 397]
9.3.7 - REFERENCES [Seite 398]
9.4 - CHAPTER 13 GRAPHENE-BASED NANOSYSTEMS FOR the DETECTION OF PROTEINIC BIOMARKERS OF DISEASE: IMPLICATION IN TRANSLATIONAL MEDICINE [Seite 401]
9.4.1 - 13.1 INTRODUCTION [Seite 401]
9.4.2 - 13.2 STRUCTURAL AND PHYSICOCHEMICAL PROPERTIES OF GRAPHENE AND MAIN DERIVATIVES [Seite 403]
9.4.3 - 13.3 GRAPHENE AND DERIVATIVES?BASED BIOSENSING NANOSYSTEMS AND APPLICATIONS [Seite 406]
9.4.4 - 13.4 CONCLUSION AND PERSPECTIVES [Seite 413]
9.4.5 - CONFLICT OF INTEREST [Seite 414]
9.4.6 - ABBREVIATIONS [Seite 414]
9.4.7 - REFERENCES [Seite 415]
9.5 - CHAPTER 14 MODELING BRAIN DISORDERS IN SILICON NANOTECHNOLOGIES [Seite 425]
9.5.1 - 14.1 INTRODUCTION [Seite 425]
9.5.2 - 14.2 THE BioRC PROJECT [Seite 426]
9.5.3 - 14.3 BACKGROUND: BioRC NEURAL CIRCUITS [Seite 428]
9.5.4 - 14.4 MODELING SYNAPSES WITH CNT TRANSISTORS [Seite 432]
9.5.5 - 14.5 MODELING OCD WITH HYBRID CMOS/NANO CIRCUITS [Seite 434]
9.5.6 - 14.6 THE BIOLOGICAL CORTICAL NEURON AND HYBRID ELECTRONIC CORTICAL NEURON [Seite 435]
9.5.7 - 14.7 BIOLOGICAL OCD CIRCUIT AND BIOMIMETIC MODEL [Seite 436]
9.5.8 - 14.8 INDIRECT PATHWAY: THE BRAKING MECHANISM [Seite 437]
9.5.9 - 14.9 DIRECT PATHWAY: THE ACCELERATOR [Seite 438]
9.5.10 - 14.10 TYPICAL AND ATYPICAL RESPONSES [Seite 439]
9.5.11 - 14.11 MODELING SCHIZOPHRENIC HALLUCINATIONS WITH HYBRID CMOS/NANO CIRCUITS [Seite 440]
9.5.12 - 14.12 EXPLANATION FOR SCHIZOPHRENIA SYMPTOMS [Seite 440]
9.5.13 - 14.13 DISINHIBITION DUE TO MISWIRING [Seite 442]
9.5.14 - 14.14 OUR HYBRID NEUROMORPHIC PREDICTION NETWORK [Seite 442]
9.5.15 - 14.15 SIMULATION RESULTS [Seite 443]
9.5.16 - 14.16 NUMERICAL ANALYSIS OF FALSE FIRING [Seite 445]
9.5.17 - 14.17 MODELING PD WITH CMOS CIRCUITS [Seite 446]
9.5.18 - 14.18 MODELING MS WITH CMOS CIRCUITS [Seite 448]
9.5.19 - 14.19 DEMYELINATION CIRCUIT [Seite 449]
9.5.20 - 14.20 CONCLUSIONS AND FUTURE TRENDS [Seite 450]
9.5.21 - REFERENCES [Seite 452]
9.6 - CHAPTER 15 LINKING MEDICAL NANOROBOTS TO PERVASIVE COMPUTING [Seite 455]
9.6.1 - 15.1 INTRODUCTION [Seite 455]
9.6.2 - 15.2 COMPLEMENTARY FUNCTIONALITIES [Seite 456]
9.6.3 - 15.3 MAIN SPECIFICATIONS FOR SUCH NANOROBOTIC AGENTS (NANOROBOTS) [Seite 457]
9.6.4 - 15.4 MEDICAL NANOROBOTIC AGENTS-AN EXAMPLE [Seite 460]
9.6.5 - 15.5 NANOROBOTIC COMMUNICATION LINKS ALLOWING PERVASIVE COMPUTING [Seite 462]
9.6.6 - 15.6 TYPES OF INFORMATION [Seite 463]
9.6.7 - 15.7 MEDICAL NANOROBOTIC AGENTS FOR MONITORING AND EARLY DETECTION [Seite 464]
9.6.8 - 15.8 MEDICAL NANOROBOTICS AND PERVASIVE COMPUTING-MAIN CONDITIONS THAT MUST BE MET FOR ITS FEASIBILITY [Seite 466]
9.6.9 - 15.9 CONCLUSION [Seite 467]
9.6.10 - REFERENCES [Seite 468]
9.7 - CHAPTER 16 NANOMEDICINE'S TRANSVERSALITY: SOME IMPLICATIONS OF THE NANOMEDICAL PARADIGM [Seite 471]
9.7.1 - 16.1 INTRODUCTION [Seite 471]
9.7.2 - 16.2 NANOMEDICINE'S PROMISES [Seite 472]
9.7.3 - 16.3 ANALYSING IMPLICATIONS OF THE NANOMEDICINE PARADIGM [Seite 475]
9.7.4 - 16.4 THE MOLECULAR UNDERPINNINGS OF NANOMEDICINE'S TRANSVERSALITY [Seite 480]
9.7.5 - 16.5 NANOMEDICINE AS PREDICTIVE MEDICINE [Seite 481]
9.7.6 - 16.6 NANOMEDICINE AS PERSONALIZED MEDICINE [Seite 484]
9.7.7 - 16.7 NANOMEDICINE AS REGENERATIVE MEDICINE [Seite 489]
9.7.8 - 16.8 CONCLUSION [Seite 490]
9.7.9 - REFERENCES [Seite 492]
10 - Part IV Ethical and Legal Aspects of Wireless Computing in Medicine [Seite 497]
10.1 - CHAPTER 17 ETHICAL CHALLENGES OF UBIQUITOUS HEALTH CARE [Seite 499]
10.1.1 - 17.1 INTRODUCTION [Seite 499]
10.1.2 - 17.2 A PHILOSOPHICAL FRAMEWORK [Seite 502]
10.1.3 - 17.3 INFORMATION DEVIANCE [Seite 504]
10.1.4 - 17.4 THE CURRENT FRENZY [Seite 506]
10.1.5 - 17.5 GENETIC INFORMATICS [Seite 509]
10.1.6 - 17.6 UBIQUITOUS INFORMATION TECHNOLOGY [Seite 513]
10.1.7 - 17.7 STASIS VERSUS PROGRESS [Seite 516]
10.1.8 - 17.8 PROBLEMATIC ETHICS [Seite 518]
10.1.9 - 17.9 LEADERSHIP IN SCIENCE AND ENGINEERING ETHICS [Seite 520]
10.1.10 - 17.10 CONCLUSION [Seite 522]
10.1.11 - REFERENCES [Seite 523]
10.2 - CHAPTER 18 THE ETHICS OF UBIQUITOUS COMPUTING IN HEALTH CARE [Seite 531]
10.2.1 - 18.1 INTRODUCTION [Seite 531]
10.2.2 - 18.2 UBIQUITOUS COMPUTING AND THE TRANSFORMATION OF HEALTH CARE: THREE VISIONS [Seite 535]
10.2.3 - 18.3 CASE STUDY: CARDIAC IMPLANTED ELECTRICAL DEVICES [Seite 540]
10.2.4 - 18.4 ETHICAL REFLECTIONS [Seite 545]
10.2.5 - 18.5 CONCLUSIONS: THE NEED FOR SOCIO?TECHNICAL DESIGN [Seite 558]
10.2.6 - REFERENCES [Seite 561]
10.3 - CHAPTER 19 PRIVACY PROTECTION OF ELECTRONIC HEALTHCARE RECORDS IN e?HEALTHCARE SYSTEMS [Seite 565]
10.3.1 - 19.1 INTRODUCTION [Seite 565]
10.3.2 - 19.2 SECURITY AND PRIVACY CONCERNS OF EHR IN e?HEALTHCARE SYSTEMS [Seite 569]
10.3.3 - 19.3 PRIVACY LAWS AND REGULATIONS OF EHRs [Seite 571]
10.3.4 - 19.4 PRIVACY OF EHRs IN e?HEALTHCARE SYSTEMS [Seite 576]
10.3.5 - 19.5 DISCUSSION AND CONCLUSION [Seite 582]
10.3.6 - 19.6 CONTRIBUTIONS AND FUTURE RESEARCH [Seite 583]
10.3.7 - REFERENCES [Seite 585]
10.4 - CHAPTER 20 ETHICAL, PRIVACY, AND INTELLECTUAL PROPERTY ISSUES IN NANOMEDICINE [Seite 591]
10.4.1 - 20.1 INTRODUCTION [Seite 591]
10.4.2 - 20.2 ETHICAL ISSUES [Seite 592]
10.4.3 - 20.3 PRIVACY ISSUES [Seite 603]
10.4.4 - 20.4 IP ISSUES [Seite 614]
10.4.5 - 20.5 CONCLUSION [Seite 620]
10.4.6 - ACKNOWLEDGMENTS [Seite 620]
10.4.7 - REFERENCES [Seite 620]
11 - Part V Conclusion [Seite 625]
11.1 - CHAPTER 21 CONCLUDING REMARKS [Seite 627]
11.1.1 - 21.1 WIRELESS COMPUTING IN HEALTH CARE [Seite 627]
11.1.2 - 21.2 NANOMEDICINE [Seite 630]
11.1.3 - 21.3 ETHICAL, PRIVACY, AND INTELLECTUAL PROPERTY ISSUES OF NANOMEDICINE AND WIRELESS COMPUTING [Seite 633]
11.1.4 - 21.4 CONCLUSIONS [Seite 634]
11.1.5 - ACKNOWLEDGMENTS [Seite 634]
11.1.6 - REFERENCES [Seite 634]
12 - Index [Seite 637]
13 - EULA [Seite 660]

Inhalt (PDF)

Systemvoraussetzungen

Als PDF speichern Als Link merken